Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance

Area of Science:

• Oncology
• Biochemistry
• Pharmacology

Background:

• 5-Fluorouracil (5-FU) is a vital chemotherapy for various cancers, especially when targeted therapies are absent.
• Chemoresistance significantly limits the effectiveness of 5-FU, necessitating novel therapeutic strategies.
• The balance of reactive oxygen species (ROS) and antioxidants differs between normal and cancer cells.

Purpose of the Study:

• To review compounds and cellular targets that modulate ROS generation.
• To explore strategies for overcoming 5-FU resistance by targeting ROS.

Main Methods:

• Literature review of studies on 5-FU resistance.
• Analysis of compounds and endogenous targets affecting ROS.
• Summary of mechanisms for modulating ROS to enhance chemotherapy.

Main Results:

• Selected compounds and cellular targets can modulate ROS levels.
• Altering ROS balance presents a viable approach to overcome 5-FU chemoresistance.
• Modulating ROS may restore sensitivity to 5-FU in resistant cancer cells.

Conclusions:

• Targeting ROS is a promising strategy to combat 5-FU resistance.
• Further research into ROS-modulating agents could lead to improved cancer treatments.
• Understanding ROS dynamics is crucial for developing effective chemoresistance-overcoming therapies.